duloxetine hydrochloride has been researched along with Anxiety in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 22 (75.86) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Joseph, TP; Lin, SL; Sai, LY; Schachner, M; Zhou, F | 1 |
| Chen, J; Zhang, K; Zhu, J | 1 |
| Kimura, M; Onda, A | 1 |
| Enomoto, T; Hasegawa, R; Hori, N; Inada, E; Isek, M; Katsuta, Y; Koh, K; Saito, R; Sugasawa, Y; Sugita, M; Takahashi, Y; Yamaguchi, K | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA | 1 |
| Cohen, LS; Connors, S; Freeman, MP; Hirschberg, AM; Joffe, H; Petrillo, LF; Regan, S; Wang, B | 1 |
| Alain, B; Beatrix, R; Erich, S; Heinz, B; Holger, H; Lorenzo, P; Markus, R | 1 |
| DU, XN; Huang, F; Huang, ZF; Li, Y; Zhang, SL; Zhu, J | 1 |
| Alam, MY; Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Serenko, M | 1 |
| Berggren, L; Gilaberte, I; Lenox-Smith, A; Pérez, V; Quail, D; Romera, I | 1 |
| Skelly, MJ; Weiner, JL | 1 |
| Arulpragasam, AR; Chou, T; Corse, AK; Deckersbach, T; Dougherty, DD; Duffy, A; Jenike, MA; Keuthen, NJ | 1 |
| Ball, SG; Escobar, R; Lipsius, S | 1 |
| Carter, E; Chappell, AE; Skelly, MJ; Weiner, JL | 1 |
| Bouhassira, D; Choy, E; Cruccu, G; Freynhagen, R; Kosek, E; Lenox-Smith, A; Lledó, A; Marchettini, P; Micó, JA; Perrot, S; Petto, H; Skljarevski, V; Späth, M; Tesfaye, S; Tölle, T; Wilhelm, S | 1 |
| Baldwin, DS; Bamford, S; Bishop, FL; Garner, M; Kwakye, IN; Pinkney, V | 1 |
| Cheng, W; Hu, J; Jiang, H; Li, X; Liu, M; Ma, Y; Sun, A; Wang, Q; Wang, Y; Zhang, X | 1 |
| Guski, LS; Gøtzsche, PC; Maund, E | 1 |
| Begley, A; Dew, MA; Karp, JF; Miller, MD; Reynolds, CF; Weiner, DK | 1 |
| Aung, GL; Kawamoto, LS; O'Brien, JG; Tien, PG | 1 |
| Chiesa, A; De Ronchi, D; Mencacci, C; Nasso, ED; Serretti, A | 1 |
| Kozumplik, O; Uzun, S | 1 |
| Ahl, J; Arnold, LM; Gaynor, PJ; Wang, F; Wohlreich, MM | 1 |
| Calabrese, F; Guidotti, G; Mancini, M; Molteni, R; Racagni, G; Riva, MA | 1 |
| Karaiskos, D; Paparrigopoulos, T; Spengos, K; Tzavellas, E; Vassilopoulou, S | 1 |
| Detke, MJ; Dunner, DL; Goldstein, DJ; Lu, Y; Mallinckrodt, C | 1 |
| Cohen, LS; Joffe, H; Koch, JK; Petrillo, LF; Soares, CN; Somley, BL; Viguera, AC | 1 |
| Bria, P; Catalano, V; Harnic, D; Janiri, L; Mazza, M | 1 |
| Möller, HJ; Müller, N; Riedel, M; Schennach, R | 1 |
2 review(s) available for duloxetine hydrochloride and Anxiety
| Article | Year |
|---|---|
Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.
Topics: Affective Symptoms; Akathisia, Drug-Induced; Antidepressive Agents; Anxiety; Duloxetine Hydrochloride; Female; Humans; Mental Disorders; Psychoses, Substance-Induced; Randomized Controlled Trials as Topic; Risk Assessment; Sleep Initiation and Maintenance Disorders; Suicidal Ideation; Treatment Outcome; Urinary Incontinence, Stress; Violence | 2017 |
Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Topics: Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Pain; Peripheral Nervous System Diseases; Practice Patterns, Physicians'; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2008 |
13 trial(s) available for duloxetine hydrochloride and Anxiety
| Article | Year |
|---|---|
Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Hot Flashes; Humans; Menopause; Middle Aged; Patient Selection; Severity of Illness Index; Thiophenes | 2013 |
[Impact of duloxetine on depression and anxiety in patients with ankylosing spondylitis: a case-control study].
Topics: Adult; Analgesics; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Pain; Spondylitis, Ankylosing; Thiophenes; Young Adult | 2013 |
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Suicidal Ideation; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Weight Gain; Young Adult | 2014 |
Open-label study of duloxetine for the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Anxiety; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotropic Drugs; Quality of Life; Thiophenes; Treatment Outcome; Young Adult | 2015 |
Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety; Anxiety Disorders; Argentina; Austria; Canada; Depression; Double-Blind Method; Duloxetine Hydrochloride; Female; Germany; Humans; Male; Mexico; Poland; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Spain; Treatment Outcome; United Kingdom; United States | 2015 |
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Topics: Affect; Age Factors; Aged; Analgesics; Anticonvulsants; Antidepressive Agents; Anxiety; Depression; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Pregabalin; Psychiatric Status Rating Scales; Treatment Outcome | 2016 |
Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.
Topics: Adult; Altruism; Antidepressive Agents; Anxiety; Duloxetine Hydrochloride; Female; Healthy Volunteers; Humans; Male; Patient Selection; Serotonin and Noradrenaline Reuptake Inhibitors; Young Adult | 2016 |
Clinical and demographic predictors of improvement during duloxetine treatment in patients with major depression: an open-label study.
Topics: Adult; Antidepressive Agents; Anxiety; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Thiophenes; Treatment Outcome | 2011 |
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Motor Activity; Musculoskeletal Pain; Pain Threshold; Patient Satisfaction; Placebos; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2011 |
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
Topics: Activities of Daily Living; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Depression; Duloxetine Hydrochloride; Fatigue; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sertraline; Stroke; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2012 |
Duloxetine in treatment of anxiety symptoms associated with depression.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Severity of Illness Index; Surveys and Questionnaires; Thiophenes | 2003 |
Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine.
Topics: Adult; Anxiety; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Hot Flashes; Humans; Middle Aged; Pain; Postmenopause; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2007 |
Duloxetine for premenstrual dysphoric disorder: a pilot study.
Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Female; Humans; Pilot Projects; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Time Factors; Treatment Outcome | 2008 |
14 other study(ies) available for duloxetine hydrochloride and Anxiety
| Article | Year |
|---|---|
Duloxetine ameliorates valproic acid-induced hyperactivity, anxiety-like behavior, and social interaction deficits in zebrafish.
Topics: Animals; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Duloxetine Hydrochloride; Prenatal Exposure Delayed Effects; Social Behavior; Social Interaction; Valproic Acid; Zebrafish | 2022 |
Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder.
Topics: Anxiety; Anxiety Disorders; C-Reactive Protein; Comorbidity; Depression; Duloxetine Hydrochloride; Flunarizine; Humans; Interleukin-6; Migraine Disorders; Tumor Necrosis Factor-alpha | 2022 |
Reduction in anxiety during treatment with exercise and duloxetine is related to improvement of low back pain-related disability in patients with non-specific chronic low back pain.
Topics: Adult; Aged; Anxiety; Chronic Pain; Combined Modality Therapy; Disabled Persons; Duloxetine Hydrochloride; Exercise Therapy; Female; Humans; Low Back Pain; Male; Middle Aged; Prospective Studies | 2020 |
[With the Characteristics of Chronic Pain Patients, Can the Therapeutic Effect of Antidepressant Duloxetine be Predicted?].
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Chronic Pain; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies | 2016 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride | 2013 |
Postictal ventricular tachycardia after electroconvulsive therapy treatment associated with a lithium-duloxetine combination.
Topics: Androstanols; Anesthesia; Antidepressive Agents; Antimanic Agents; Anxiety; Bipolar Disorder; Duloxetine Hydrochloride; Electrocardiography; Electroconvulsive Therapy; Female; Humans; Lithium Carbonate; Middle Aged; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Psychomotor Agitation; Recurrence; Rocuronium; Succinylcholine; Tachycardia, Ventricular; Thiophenes | 2013 |
Individual residual symptoms and functional impairment in patients with depression.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Sleep Wake Disorders; Thiophenes | 2014 |
Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Duloxetine Hydrochloride; Ethanol; Male; Prazosin; Rats; Rats, Long-Evans; Self Administration; Thiophenes | 2014 |
Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling.
Topics: Aging; Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Central Nervous System Depressants; Conditioning, Psychological; Duloxetine Hydrochloride; Ethanol; Extinction, Psychological; Fear; Male; Norepinephrine; Prazosin; Propranolol; Random Allocation; Rats, Long-Evans; Self Administration; Social Isolation | 2015 |
Duloxetine prevents the effects of prenatal stress on depressive-like and anxiety-like behavior and hippocampal expression of pro-inflammatory cytokines in adult male offspring rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Body Weight; Cytokines; Disease Models, Animal; Duloxetine Hydrochloride; Exploratory Behavior; Female; Gene Expression Regulation; Gestational Age; Hippocampus; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Swimming; Water Deprivation | 2016 |
Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study.
Topics: Aged; Anxiety; Chronic Disease; Comorbidity; Depressive Disorder, Major; Disability Evaluation; Disease Management; Duloxetine Hydrochloride; Female; Health Status; Humans; Low Back Pain; Male; Pain Measurement; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Efficacy; Sleep; Surveys and Questionnaires; Thiophenes | 2010 |
Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Cytochrome P-450 Enzyme Inhibitors; Darunavir; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; HIV Infections; HIV Protease Inhibitors; Humans; Male; Piperazines; Quinolones; Ritonavir; Sulfonamides; Thiophenes | 2010 |
Reinforcement of irritability during therapy with benzodiazepines.
Topics: Adult; Antidepressive Agents; Anxiety; Benzodiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Duloxetine Hydrochloride; Humans; Hypnotics and Sedatives; Irritable Mood; Life Change Events; Male; Oxazepam; Pyridines; Self Medication; Thiophenes; Zolpidem | 2011 |
Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Duloxetine Hydrochloride; Gene Expression Regulation; Hippocampus; Male; Memory; Phosphorylation; Prefrontal Cortex; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spatial Behavior; Stress, Psychological; Thiophenes | 2012 |